Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan

被引：22
|
作者：
Richards, S
Umbreit, JN
Fanucchi, MP
Giblin, J
Khuri, F
机构：
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
来源：
SOUTHERN MEDICAL JOURNAL | 2003年 / 96卷 / 10期
关键词：
citalopram; irinotecan; rhabdomyolysis; selective serotonin reuptake inhibitors;
D O I：
10.1097/01.SMJ.0000084311.35864.D6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 74-year-old man was admitted with rhabdomyolysis after undergoing initial treatment for gastrointestinal cancer with irinotecan. The syndrome partially resolved after the discontinuation of all of his usual medications, including his chronic selective serotonin reuptake inhibitor (SSRI). The rhabdomyolysis was exacerbated upon reinitiation of the SSRI and disappeared when the SSRI was discontinued. The combination of irinotecan and SSRI resulted in potentially lethal rhabdomyolysis.
引用
收藏
页码：1031 / 1033
页数：3
相关论文
共 50 条
  • [31] Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial
    Rosenbaum, JF
    Fava, M
    Hoog, SL
    Ascroft, RC
    Krebs, WB
    BIOLOGICAL PSYCHIATRY, 1998, 44 (02) : 77 - 87
  • [32] Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients
    Mortensen, Janne Kaergaard
    Andersen, Grethe
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (06) : 911 - 919
  • [33] Efficacy of selective serotonin reuptake inhibitor (SSRI) in patient with premature ejaculation
    Rezakhaniha, Bijan
    Sirosbakht, Soheila
    IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE, 2010, 8 (02) : 55 - 59
  • [34] Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)
    Hedenmalm, Karin
    Sundstrom, Anders
    Spigset, Olav
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (10) : 719 - 725
  • [35] Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
    C. Lindsay DeVane
    Cellular and Molecular Neurobiology, 1999, 19 : 443 - 466
  • [36] Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors
    DeVane, CL
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1999, 19 (04) : 443 - 466
  • [37] Thrombopathy induced by selective serotonin reuptake inhibitors: a case report
    Ben Said, Mehdi
    Amar, Laurence
    Smadja, David
    Rivet, Nadia
    Bertill, Sebastien
    Fischer, Anne-Marie
    Helley, Dominique
    Gaussem, Pascale
    ANNALES DE BIOLOGIE CLINIQUE, 2014, 72 (05) : 607 - 611
  • [38] Valproate prophylaxis for migraine induced by selective serotonin reuptake inhibitors
    Delva, NJ
    Horgan, SA
    Hawken, ER
    HEADACHE, 2000, 40 (03): : 248 - 251
  • [39] Selective serotonin reuptake inhibitors-associated apathy syndrome A cross sectional study
    Padala, Prasad R.
    Padala, Kalpana P.
    Majagi, Anusha S.
    Garner, Kimberly K.
    Dennis, Richard A.
    Sullivan, Dennis H.
    MEDICINE, 2020, 99 (33)
  • [40] Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain
    Viazis, Nikos
    Katopodi, Konstantina
    Karamanolis, George
    Denaxas, Konstantinos
    Varytimiadis, Lazaros
    Galanopoulos, Michail
    Tsoukali, Emmanouela
    Kamberoglou, Dimitirs
    Christidou, Angeliki
    Karamanolis, Dimitrios G.
    Papatheodoridis, George
    Mantzaris, Gerasimos J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (09) : 1054 - 1058
12345